Interplay Between HSF1 and P53 Signaling Pathways in Cancer Initiation and Progression: Non-Oncogene and Oncogene Addiction

Cellular Oncology - Germany
doi 10.1007/s13402-019-00452-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Crosstalk Between Stress-Induced NF-κB, P53 and HSF1 Signaling Pathways – Review.

IFAC Proceedings Volumes
2014English

P53: Oncogene or Anti-Oncogene?

Genes and Development
GeneticsDevelopmental Biology
1990English

DRAM2 Acts as an Oncogene in Non-Small Cell Lung Cancer and Suppresses the Expression of P53

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

P53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer

Cancer Research
Cancer ResearchOncology
2019English

SIRT3: Oncogene and Tumor Suppressor in Cancer

Cancers
Cancer ResearchOncology
2017English

Regulation of Autophagy and EMT by the Interplay Between P53 and RAS During Cancer Progression (Review)

International Journal of Oncology
Cancer ResearchOncology
2017English

ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology

Cancers
Cancer ResearchOncology
2017English

T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways

Frontiers in Oncology
Cancer ResearchOncology
2018English

MicroRNA-370 Inhibits the Progression of Non-Small Cell Lung Cancer by Downregulating Oncogene TRAF4

Oncology Reports
MedicineCancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy